{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:04:47Z","timestamp":1791493487457,"version":"4.3.4"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ejim.2017.10.006","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T11:15:57Z","timestamp":1508411757000},"page":"35-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Serology in autoimmune hepatitis: A clinical-practice approach"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5004-5029","authenticated-orcid":false,"given":"Benedetta","family":"Terziroli Beretta-Piccoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgina","family":"Mieli-Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2017.10.006_bb0005","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: international autoimmune hepatitis group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0010","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2017.10.006_bb0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0020","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","author":"European Association for the Study of the Liver","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2017.10.006_bb0025","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0030","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jhep.2010.06.032","article-title":"Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients","volume":"54","author":"Qiu","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2017.10.006_bb0035","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3109\/08916934.2011.592884","article-title":"Performance of the international classifications criteria for autoimmune hepatitis diagnosis in Mexican patients","volume":"44","author":"Mu\u00f1oz-Espinosa","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ejim.2017.10.006_bb0040","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/hep.22825","article-title":"Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients","volume":"49","author":"Muratori","year":"2009","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2013.08.004","article-title":"Autoimmune hepatitis: contrasts and comparisons in children and adults \u2014 a comprehensive review","volume":"46","author":"Floreani","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ejim.2017.10.006_bb0050","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology: current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2017.10.006_bb0055","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1056\/NEJM200004273421707","article-title":"Evaluation of abnormal liver-enzyme results in asymptomatic patients","volume":"342","author":"Pratt","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.10.006_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2008-1040641","article-title":"Natural history, clinical features, and treatment of autoimmune hepatitis","volume":"4","author":"Czaja","year":"1984","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ejim.2017.10.006_bb0065","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1233533","article-title":"Autoantibodies and their antigens in autoimmune hepatitis","volume":"29","author":"Bogdanos","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ejim.2017.10.006_bb0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the international autoimmune hepatitis group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2017.10.006_bb0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2013.08.001","article-title":"Clinical significance of autoantibodies in autoimmune hepatitis","volume":"46","author":"Liberal","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ejim.2017.10.006_bb0080","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1136\/ard.2009.127100","article-title":"ANA screening: an old test with new recommendations","volume":"69","author":"Meroni","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2017.10.006_bb0085","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","article-title":"Range of antinuclear antibodies in \u201chealthy\u201d individuals","volume":"40","author":"Tan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2017.10.006_bb0090","first-page":"619","article-title":"Seroprevalence of antinuclear antibodies in blood donors in the Yaqui Valley","volume":"82","author":"Serrano-Osuna","year":"2014","journal-title":"Cir Cir"},{"key":"10.1016\/j.ejim.2017.10.006_bb0095","series-title":"Chapter 77 - autoantibody assays: Performance, interpretation, and standardization","first-page":"1161","author":"Fritzler","year":"2014"},{"key":"10.1016\/j.ejim.2017.10.006_bb0100","first-page":"1022","article-title":"The specificity of L.E. phenomenon","volume":"45","author":"Leoni","year":"1954","journal-title":"Minerva Med"},{"key":"10.1016\/j.ejim.2017.10.006_bb0105","first-page":"25","article-title":"Presentation of two bone marrow elements; the tart cell and the L.E. cell","volume":"23","author":"Hargraves","year":"1948","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"10.1016\/j.ejim.2017.10.006_bb0110","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(56)91483-0","article-title":"Lupoid hepatitis","volume":"268","author":"Mackay","year":"1956","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2017.10.006_bb0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2013-203863","article-title":"International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","volume":"73","author":"Agmon-Levin","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2017.10.006_bb0120","first-page":"889","article-title":"Chapter 61 - hepatitis","author":"Vergani","year":"2014"},{"key":"10.1016\/j.ejim.2017.10.006_bb0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2017.10.006_bb0130","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(65)92505-5","article-title":"Antibody to smooth muscle in patients with liver disease","volume":"2","author":"Johnson","year":"1965","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ejim.2017.10.006_bb0135","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0016-5085(19)34365-3","article-title":"Smooth muscle autoantibody in \u201cautoimmune\u201d hepatitis","volume":"51","author":"Whittingham","year":"1966","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2017.10.006_bb0140","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jcp.29.5.403","article-title":"Classification of smooth muscle autoantibodies detected by immunofluorescence","volume":"29","author":"Bottazzo","year":"1976","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ejim.2017.10.006_bb0145","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/01.mcg.0000139072.38580.a0","article-title":"Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis","volume":"38","author":"Cotler","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ejim.2017.10.006_bb0150","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2249.2004.02541.x","article-title":"Anti-actin IgA antibodies in severe coeliac disease","volume":"137","author":"Granito","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ejim.2017.10.006_bb0155","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/0891693021000054066","article-title":"Smooth muscle antibodies and type 1 autoimmune hepatitis","volume":"35","author":"Muratori","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ejim.2017.10.006_bb0160","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/hep.510240515","article-title":"Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis","volume":"24","author":"Czaja","year":"1996","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jcp.2006.039404","article-title":"Diagnostic relevance of anti-filamentous actin antibodies in autoimmune hepatitis","volume":"60","author":"Liaskos","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ejim.2017.10.006_bb0170","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0175","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0180","first-page":"331","article-title":"Microsomal antibodies in active chronic hepatitis and other disorders","volume":"15","author":"Rizzetto","year":"1973","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ejim.2017.10.006_bb0185","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.1840070626","article-title":"Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: a second type of \u201cautoimmune\u201d hepatitis","volume":"7","author":"Homberg","year":"1987","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0190","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1172\/JCI113949","article-title":"Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1","volume":"83","author":"Manns","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2017.10.006_bb0195","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1073\/pnas.85.21.8256","article-title":"Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II","volume":"85","author":"Zanger","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejim.2017.10.006_bb0200","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1084\/jem.168.2.801","article-title":"Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily","volume":"168","author":"Gueguen","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.ejim.2017.10.006_bb0205","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/hep.1840040223","article-title":"Ticrynafen-associated hepatic injury: analysis of 340 cases","volume":"4","author":"Zimmerman","year":"1984","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0210","first-page":"232","article-title":"Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent","volume":"54","author":"Crivelli","year":"1983","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ejim.2017.10.006_bb0215","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510260438","article-title":"Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease","volume":"26","author":"Manns","year":"1997","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0220","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.510260305","article-title":"Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile","volume":"26","author":"Cassani","year":"1997","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0225","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/hep.1840160304","article-title":"Liver\/kidney microsome antibody type 1 and hepatitis C virus infection","volume":"16","author":"Lunel","year":"1992","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0230","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/gut.37.3.406","article-title":"Heterogeneity of liver\/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease","volume":"37","author":"Muratori","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2017.10.006_bb0235","first-page":"1481","article-title":"Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus\/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease","volume":"170","author":"Kerkar","year":"2003","journal-title":"J Immunol Baltim Md 1950"},{"key":"10.1016\/j.ejim.2017.10.006_bb0240","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI115443","article-title":"LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase","volume":"88","author":"Manns","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2017.10.006_bb0245","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00281-009-0170-7","article-title":"Autoimmune hepatitis","volume":"31","author":"Vergani","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.ejim.2017.10.006_bb0250","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0255","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","article-title":"Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis","volume":"116","author":"Lapierre","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2017.10.006_bb0260","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1053\/jhep.2001.27179","article-title":"Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1","volume":"34","author":"Muratori","year":"2001","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0265","first-page":"58","article-title":"Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease","volume":"21","author":"Han","year":"1995","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0270","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.36.5.749","article-title":"Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection","volume":"36","author":"Lenzi","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2017.10.006_bb0275","first-page":"921","article-title":"Hypergammaglobulin\u00e4mische chronisch aktive Hepatitis mit Nachweis von Leber-Pankreas-spezifischen komplementbindenden Autoantik\u00f6rpern","volume":"87","author":"Berg","year":"1981","journal-title":"Verh Dtsch Ges Inn Med"},{"key":"10.1016\/j.ejim.2017.10.006_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840180102","article-title":"Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis","volume":"18","author":"Stechemesser","year":"1993","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0285","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","article-title":"Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen","volume":"1","author":"Manns","year":"1987","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ejim.2017.10.006_bb0290","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ejim.2017.10.006_bb0295","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.89.20.9739","article-title":"Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion","volume":"89","author":"Gelpi","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejim.2017.10.006_bb0300","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2249.2000.01280.x","article-title":"Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis","volume":"121","author":"Costa","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ejim.2017.10.006_bb0305","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/jhep.2001.22218","article-title":"Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis","volume":"33","author":"Volkmann","year":"2001","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0310","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/jhep.2002.32092","article-title":"Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease","volume":"35","author":"Ma","year":"2002","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0315","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.51.2.259","article-title":"Establishment of standardised SLA\/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics","volume":"51","author":"Baeres","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2017.10.006_bb0320","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08916930410001686260","article-title":"Anti-soluble liver antigen (SLA) antibodies in chronic HCV infection","volume":"37","author":"Vitozzi","year":"2004","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ejim.2017.10.006_bb0325","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/0891693021000056712","article-title":"Anti-soluble liver antigen\/liver-pancreas (SLA\/LP) antibodies in pediatric patients with autoimmune hepatitis","volume":"35","author":"Vitozzi","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ejim.2017.10.006_bb0330","unstructured":"doi: 10.1016\/S0168-8278(07)62258-2 - pdf n.d. http:\/\/www.journal-of-hepatology.eu\/article\/S0168-8278(07)62258-2\/pdf (accessed August 30, 2017)."},{"key":"10.1016\/j.ejim.2017.10.006_bb0335","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-017-8616-5","article-title":"Cutaneous manifestations of ANCA-associated small vessels vasculitis","author":"Marzano","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.ejim.2017.10.006_bb0340","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","article-title":"Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis","volume":"1","author":"van der Woude","year":"1985","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ejim.2017.10.006_bb0345","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM198806233182504","article-title":"Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis","volume":"318","author":"Falk","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.10.006_bb0350","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/hep.510280207","article-title":"Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins","volume":"28","author":"Terjung","year":"1998","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0355","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3748\/wjg.v13.i14.2028","article-title":"Utility of serological markers in inflammatory bowel diseases: gadget or magic?","volume":"13","author":"Papp","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2017.10.006_bb0360","first-page":"458","article-title":"Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis","volume":"37","author":"Hov","year":"2017","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.ejim.2017.10.006_bb0365","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/hep.1840170310","article-title":"Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases","volume":"17","author":"Mulder","year":"1993","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0370","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.510250510","article-title":"Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis","volume":"25","author":"Zauli","year":"1997","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.ejim.2017.10.006_bb0375","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0016-5085(95)90215-5","article-title":"High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis","volume":"108","author":"Targan","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2017.10.006_bb0380","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/0016-5085(95)90785-8","article-title":"Antineutrophil cytoplasmic antibodies in autoimmune hepatitis","volume":"109","author":"Bansi","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2017.10.006_bb0385","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0168-8278(99)80342-0","article-title":"Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis","volume":"31","author":"Kanzler","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2017.10.006_bb0390","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1572-0241.2002.05479.x","article-title":"Antibodies to soluble liver antigen\/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis","volume":"97","author":"Czaja","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2017.10.006_bb0395","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/0891693021000056721","article-title":"Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease","volume":"35","author":"Gregorio","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ejim.2017.10.006_bb0400","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/gast.2001.20223","article-title":"Autoantibodies in liver disease","volume":"120","author":"Czaja","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2017.10.006_bb0405","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3748\/wjg.14.3781","article-title":"Autoantibodies in primary sclerosing cholangitis","volume":"14","author":"Hov","year":"2008","journal-title":"World J Gastroenterol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517304144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517304144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T18:08:23Z","timestamp":1570212503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620517304144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":81,"alternative-id":["S0953620517304144"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2017.10.006","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serology in autoimmune hepatitis: A clinical-practice approach","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2017.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}